Cervical carcinosarcoma presented in advanced stage after high grade cervical displasia.

Q3 Pharmacology, Toxicology and Pharmaceutics
Volkan Karataşlı, Selçuk Erkılınç, Behzat Can, İlker Çakır, Orhan Temel, Mehmet Gökçü, Muzaffer Sancı
{"title":"Cervical carcinosarcoma presented in advanced stage after high grade cervical displasia.","authors":"Volkan Karataşlı,&nbsp;Selçuk Erkılınç,&nbsp;Behzat Can,&nbsp;İlker Çakır,&nbsp;Orhan Temel,&nbsp;Mehmet Gökçü,&nbsp;Muzaffer Sancı","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Cervical carcinosarcomas (Malignant Mixed Mullerian Tumour [MMMT] ) are very rare neoplasms. Fewer than 100 cases were documented until recently. Because of the rarity, etiologic factors, prognosis and treatment modalities are unclear. A 53 year-old woman presented with postmenauposal vaginal bleeding and abnormal cervical cytology. Cervical biopsy followed by loop electrosurgical excision procedure (LEEP) and cold knife conisation (CKC) was documented as cervical intraepithelial neoplasia III (CIN III). Without follow-up, two years later, the patient was referred with a cervical 6,5 cm mass invading vagina, parametriums and rectum. Biopsy was reported as cervical carcinosarcoma with squmous carcinoma and homologous sarcoma component. Neoadjuvant chemotherapy provided partial response. Subsequently external beam whole pelvis radiotherapy with chemotherapy and brachytherapy was applied. In despite of the treatment, the patient developed sistemic recurrence and died of disease within 10 months. In previous reports most of the patients were in early stage and had better prognosis than uterine carcinosarcomas. Here in we present a case who had a history of high-grade cervical displasia and presented at advanced stage, managed with neoadjuvant chemotherapy and definitive chemoradiotherapy.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Experimental Therapeutics and Oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Cervical carcinosarcomas (Malignant Mixed Mullerian Tumour [MMMT] ) are very rare neoplasms. Fewer than 100 cases were documented until recently. Because of the rarity, etiologic factors, prognosis and treatment modalities are unclear. A 53 year-old woman presented with postmenauposal vaginal bleeding and abnormal cervical cytology. Cervical biopsy followed by loop electrosurgical excision procedure (LEEP) and cold knife conisation (CKC) was documented as cervical intraepithelial neoplasia III (CIN III). Without follow-up, two years later, the patient was referred with a cervical 6,5 cm mass invading vagina, parametriums and rectum. Biopsy was reported as cervical carcinosarcoma with squmous carcinoma and homologous sarcoma component. Neoadjuvant chemotherapy provided partial response. Subsequently external beam whole pelvis radiotherapy with chemotherapy and brachytherapy was applied. In despite of the treatment, the patient developed sistemic recurrence and died of disease within 10 months. In previous reports most of the patients were in early stage and had better prognosis than uterine carcinosarcomas. Here in we present a case who had a history of high-grade cervical displasia and presented at advanced stage, managed with neoadjuvant chemotherapy and definitive chemoradiotherapy.

宫颈高度增生后出现的晚期宫颈癌肉瘤。
目的:宫颈癌肉瘤(恶性混合苗勒氏瘤)是一种非常罕见的肿瘤。直到最近,记录在案的病例还不到100例。由于罕见,病因、预后和治疗方式尚不清楚。一个53岁的妇女提出了绝经后阴道出血和宫颈细胞学异常。宫颈活检后行环形电切术(LEEP)和冷刀锥切术(CKC),记录为宫颈上皮内瘤变III (CIN III)。未随访,两年后,患者因宫颈6,5 cm肿块侵入阴道,参数和直肠而转诊。活检报告为宫颈癌肉瘤伴鳞状癌和同源肉瘤成分。新辅助化疗提供部分缓解。随后行全骨盆外束放疗加近距离化疗。尽管接受了治疗,但患者出现了系统性复发,并在10个月内死于疾病。在以往的报道中,大多数患者处于早期,预后优于子宫癌肉瘤。在这里,我们提出了一个病例,他有高度宫颈增生的历史,并在晚期提出,与新辅助化疗和明确放化疗管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信